Berkeley Lovelace Jr.
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Latest from Berkeley Lovelace Jr.
House lawmakers slam pharmacy middlemen over sky-high drug prices
Democratic and Republican lawmakers found common ground with one another during an oversight committee hearing Tuesday, blaming executives from three major pharmacy middlemen groups for the sky-high prescription drug prices in the United States.
What a Kamala Harris presidency would mean for health care in America
A Kamala Harris presidency could have far-reaching consequences for the U.S. health care system, from abortion rights to insurance coverage to drug pricing.
Harris' frank talk about abortion and its impact on women's health might energize voters
Vice President Kamala Harris's candid stance on abortion might shift the national conversation on women’s health, following Biden’s decision not to seek re-election, experts say.
FDA once again pushes back proposal to ban cancer-linked formaldehyde in hair relaxers
The agency's self-imposed target date for proposing a ban on formaldehyde in hair products was pushed to July and will be pushed again to September.
Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss study
Tirzepatide, the active ingredient in Eli Lilly’s Mounjaro and Zepbound, leads to more weight loss than semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, new research suggests.
Ozempic may be linked to condition that causes blindness, but more research is needed
People taking Ozempic and Wegovy may be at increased risk of developing a debilitating eye condition that can cause irreversible vision loss, a study published in JAMA Ophthalmology finds.
FDA approves Eli Lilly's Alzheimer's drug Kisunla
The FDA approved a new Alzheimer’s drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities.
Biden and Trump's back-and-forth on insulin fails to address the sky-high cost of health care
During Thursday night’s debate, President Joe Biden and former President Donald Trump spent a considerable amount of time trying to claim credit for lowering the high cost of insulin.
Fact-checking Biden and Trump's claims at the first debate
Trump made a series of misleading claims on topics ranging from Jan. 6 to terrorism to taxes at the first 2024 presidential debate, while Biden flubbed some facts.
House committee passes bill that would allow Medicare to cover weight loss drugs
For more than two decades, a law has prohibited Medicare from paying for weight loss drugs, cutting off access to millions of potential patients who could stand to benefit.
Health care just as important as economy. What experts want Biden and Trump to address.
When Biden and Trump debate Thursday, health policy experts say tackling the exorbitant cost of health care is as much a top issue for voters as the U.S. economy.
